DE69425970D1 - Benzol-derivate, verwendbar für ischämische erkrankungen - Google Patents
Benzol-derivate, verwendbar für ischämische erkrankungenInfo
- Publication number
- DE69425970D1 DE69425970D1 DE69425970T DE69425970T DE69425970D1 DE 69425970 D1 DE69425970 D1 DE 69425970D1 DE 69425970 T DE69425970 T DE 69425970T DE 69425970 T DE69425970 T DE 69425970T DE 69425970 D1 DE69425970 D1 DE 69425970D1
- Authority
- DE
- Germany
- Prior art keywords
- formula
- ischemic diseases
- chem
- hydrogen atom
- inhibitory action
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15224893 | 1993-06-23 | ||
PCT/JP1994/001009 WO1995000471A1 (fr) | 1993-06-23 | 1994-06-23 | Derive du benzene utile contre les ischemies |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69425970D1 true DE69425970D1 (de) | 2000-10-26 |
DE69425970T2 DE69425970T2 (de) | 2001-01-18 |
Family
ID=15536338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69425970T Expired - Fee Related DE69425970T2 (de) | 1993-06-23 | 1994-06-23 | Benzol-derivate, verwendbar für ischämische erkrankungen |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0705816B1 (de) |
KR (1) | KR100262419B1 (de) |
CN (1) | CN1038582C (de) |
AT (1) | ATE196464T1 (de) |
CA (1) | CA2165662A1 (de) |
CZ (1) | CZ289716B6 (de) |
DE (1) | DE69425970T2 (de) |
ES (1) | ES2152319T3 (de) |
FI (1) | FI956151A (de) |
HU (1) | HUT75102A (de) |
NO (1) | NO305956B1 (de) |
PL (1) | PL176687B1 (de) |
RO (1) | RO115518B1 (de) |
RU (1) | RU2127254C1 (de) |
SK (1) | SK164795A3 (de) |
TW (1) | TW403734B (de) |
UA (1) | UA43338C2 (de) |
WO (1) | WO1995000471A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5998452A (en) * | 1993-06-23 | 1999-12-07 | Chugai Seiyaku Kabushiki Kaisha | Benzene derivatives, compositions and methods for treating ischemic diseases |
WO1996019210A1 (fr) * | 1994-12-22 | 1996-06-27 | Chugai Seiyaku Kabushiki Kaisha | Medicament contre les maladies ischemiques |
EP0938676A1 (de) * | 1996-11-12 | 1999-09-01 | Eli Lilly And Company | Kombinatorisches verfahern zur herstellung von thiazolidinon-biblotheken |
AU4411399A (en) | 1998-06-05 | 1999-12-20 | Eli Lilly And Company | Potassium channel inhibitors |
US6174908B1 (en) | 1999-05-10 | 2001-01-16 | Icagen, Inc. | Potassium channel inhibitors |
JP2004002206A (ja) * | 2000-07-26 | 2004-01-08 | Chugai Pharmaceut Co Ltd | 光学活性なチアゾリジノン誘導体の製造方法 |
IL159765A0 (en) * | 2001-07-16 | 2004-06-20 | Euro Celtique Sa | Aryl substituted thiazolidinone derivatives and pharmaceutical compositions containing the same |
WO2004017965A1 (en) * | 2002-08-23 | 2004-03-04 | Ionix Pharmaceuticals Limited | 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain |
FR3120368B1 (fr) * | 2021-03-02 | 2024-01-19 | Michelin & Cie | Monomères contenant un motif 4-thiazolidinone et leurs polycondensats polyamide, polyester et polyuréthane. |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2623048A (en) * | 1948-04-05 | 1952-12-23 | Parke Davis & Co | 4-thiazolidone derivatives and process for preparing the same |
US2520179A (en) * | 1949-02-02 | 1950-08-29 | Sterling Drug Inc | 4-thiazolidones and a method for preparation thereof |
US3309377A (en) * | 1964-10-19 | 1967-03-14 | Sterling Drug Inc | 3-[(2-oxazolidinone-3-yl)-alkyl]-4-thiazolidinones and their preparation |
FR2504528A1 (fr) * | 1981-04-23 | 1982-10-29 | Choay Sa | Dialcoxy (2,4) benzenesulfonamides n-substitues |
US4820715A (en) * | 1984-06-28 | 1989-04-11 | Bristol-Myers Company | Anti-emetic quinuclidinyl benzamides |
IL79648A (en) * | 1985-08-09 | 1991-12-12 | Lilly Co Eli | Pharmaceutical anti-inflammatory and ischemia preventing compositions containing di-t-butylphenol derivatives,some such novel compounds and process for their preparation |
GB8820442D0 (en) * | 1988-08-30 | 1988-09-28 | Usherwood P N R | Therapeutic polyamine amides |
AU7317391A (en) * | 1990-02-14 | 1991-09-03 | Chugai Seiyaku Kabushiki Kaisha | Inhibitor of denatured ldl formation |
-
1994
- 1994-06-23 WO PCT/JP1994/001009 patent/WO1995000471A1/ja active IP Right Grant
- 1994-06-23 KR KR1019950705894A patent/KR100262419B1/ko not_active IP Right Cessation
- 1994-06-23 CN CN94192846A patent/CN1038582C/zh not_active Expired - Fee Related
- 1994-06-23 CA CA002165662A patent/CA2165662A1/en not_active Abandoned
- 1994-06-23 UA UA95125450A patent/UA43338C2/uk unknown
- 1994-06-23 PL PL94312471A patent/PL176687B1/pl unknown
- 1994-06-23 HU HU9503775A patent/HUT75102A/hu unknown
- 1994-06-23 CZ CZ19953450A patent/CZ289716B6/cs not_active IP Right Cessation
- 1994-06-23 DE DE69425970T patent/DE69425970T2/de not_active Expired - Fee Related
- 1994-06-23 ES ES94918559T patent/ES2152319T3/es not_active Expired - Lifetime
- 1994-06-23 RO RO95-02265A patent/RO115518B1/ro unknown
- 1994-06-23 EP EP94918559A patent/EP0705816B1/de not_active Expired - Lifetime
- 1994-06-23 RU RU96102006/04A patent/RU2127254C1/ru not_active IP Right Cessation
- 1994-06-23 SK SK1647-95A patent/SK164795A3/sk unknown
- 1994-06-23 AT AT94918559T patent/ATE196464T1/de not_active IP Right Cessation
- 1994-06-23 TW TW083105734A patent/TW403734B/zh not_active IP Right Cessation
-
1995
- 1995-12-20 NO NO955176A patent/NO305956B1/no unknown
- 1995-12-20 FI FI956151A patent/FI956151A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
UA43338C2 (uk) | 2001-12-17 |
ES2152319T3 (es) | 2001-02-01 |
NO305956B1 (no) | 1999-08-23 |
NO955176L (no) | 1996-02-23 |
FI956151A0 (fi) | 1995-12-20 |
AU674239B2 (en) | 1996-12-12 |
SK164795A3 (en) | 1996-10-02 |
FI956151A (fi) | 1996-02-19 |
DE69425970T2 (de) | 2001-01-18 |
PL312471A1 (en) | 1996-04-29 |
CN1127502A (zh) | 1996-07-24 |
CN1038582C (zh) | 1998-06-03 |
HU9503775D0 (en) | 1996-02-28 |
WO1995000471A1 (fr) | 1995-01-05 |
EP0705816A1 (de) | 1996-04-10 |
KR100262419B1 (ko) | 2000-09-01 |
AU6982994A (en) | 1995-01-17 |
RO115518B1 (ro) | 2000-03-30 |
HUT75102A (en) | 1997-04-28 |
CA2165662A1 (en) | 1995-01-05 |
ATE196464T1 (de) | 2000-10-15 |
CZ289716B6 (cs) | 2002-03-13 |
EP0705816A4 (de) | 1997-05-28 |
RU2127254C1 (ru) | 1999-03-10 |
EP0705816B1 (de) | 2000-09-20 |
TW403734B (en) | 2000-09-01 |
PL176687B1 (pl) | 1999-07-30 |
CZ345095A3 (en) | 1996-12-11 |
NO955176D0 (no) | 1995-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69716226D1 (de) | Difluoroprostaglandin-Derivate und ihre Anwendung | |
LU91210I2 (fr) | Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER) | |
DK0447285T3 (da) | Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem | |
PT1063228E (pt) | Derivados de cicloalcenos processo para a sua preparacao e utilizacao | |
MX9307332A (es) | 3-(aminoalquilamino)-1,2-bencisoxasoles substituidos y compuestos relacionados. | |
AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
PT1216245E (pt) | Derivados sulfonil-hidrazida farmaceuticamente activos | |
DE69425970D1 (de) | Benzol-derivate, verwendbar für ischämische erkrankungen | |
ATE268751T1 (de) | Biphenylamidin-derivate | |
DE69001722D1 (de) | Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt. | |
DK0420121T3 (da) | Antitumormiddel | |
ATE115545T1 (de) | Aralkylamin-verbindungen. | |
DK0420224T3 (da) | Anthihepatopatisk middel | |
ATE146481T1 (de) | Epoxysuccinamidsäurederivat | |
NO921282D0 (no) | Benzotiazolderivater og deres anvendelse | |
ES2118993T3 (es) | Procedimiento para la preparacion de derivados de sulfonilurea. | |
ATE105565T1 (de) | Pradimicinderivate. | |
ES2149180T3 (es) | Derivado de pirazolotiazolopirimidina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |